Life Sciences

XLerateHealth Incubator In Flint Seeks Applicants For Its 2021 Startup Cohort

FLINT - XLerateHealth, a healthcare accelerator, is starting to recruit for its 2021 Flint Startup Cohort. Sebastian Alvim from XLerateHealth will be on MITech TV at 2 pm Feb. 15 to discuss. But here are some of the details: Calling all Flint and Genesee county healthcare entrepreneurs, innovators and startups! Apply for the 2021 XLerateHealth

By |2021-02-13T17:22:36-05:00February 13th, 2021|Featured, Life Sciences, Life Sciences/Biotech|

MMS Contract Pharma Researcher Joins Healthcare Alliance

CANTON TWP.–MMS Holdings, a contract research organization for the pharmaceutical industry, has joined the Decentralized Trials and Research Alliance, an organization launched in December to unite healthcare companies, regulators, patient groups and research organizations to make clinical trial participation widely accessible by advancing policies, research practices, and new technologies in decentralized clinical research. “As a

By |2021-01-30T11:14:45-05:00January 30th, 2021|Life Sciences, Life Sciences/Biotech|

Report: 29 Percent Of US Broadband Households Very Likely To Purchase a Connected Health Product in the Next 12 Months

DALLAS – Twenty-nine percent of US broadband households plan to buy a connected health product over the next 23 months a new report indicates. The study, by Parks Associates, also shows US broadband households increased from 15 percent in 2019 to 41 percent in 2020. "The COVID-19 pandemic caused a massive increase in telehealth and

By |2021-01-24T18:27:39-05:00January 23rd, 2021|Featured, Internet, Life Sciences|

Scientists Closer To Developing ‘Smart’ Stem Cells From Human Fat

SYDNEY, Australia - A new type of stem cell—that is, a cell with regenerative abilities—could be closer on the horizon, a new study led by an Australian University shows. The stem cells (called induced multipotent stem cells, or iMS) can be made from easily accessible human cells—in this case, fat—and reprogrammed to act as stem cells. The results

By |2021-01-15T15:09:56-05:00January 15th, 2021|Life Sciences|

Stryker Acquires Florida-Based Sensor Technology Maker

KALAMAZOO — Stryker Corp. acquired Dania Beach, Fla.-based OrthoSensor Inc., a producer of sensor technology for musculoskeletal care and total joint replacement. OrthoSensor’s technology advancement, said in a press release, when “coupled with expanded data analytics and increasing computational power, will strengthen the foundation of Stryker’s digital ecosystem.” “Smart devices and implants will play a big role in

COVID-19 Update: Post Thanksgiving Pandemic Surge Just Before Xmas

ANN ARBOR - Infectious disease expert Fred Brown, who works with nations and states as an unpaid epidemiologst, warns that a surge of COVID-19 will probably be manifested by Thanksgiving gatherings, just in time for the late December holidays. Trained as a medicinal biochemist, Brown has been on the discovery, development and/or launch teams of

By |2020-12-05T18:28:40-05:00December 5th, 2020|Featured, Life Sciences, Life Sciences/Biotech, mitechtv|

UM Professor Named To MichBio Board

ANN ARBOR—Officials at MichBio, the state’s life sciences industry lobbying group, announced the addition of Lola Eniola-Adefeso, university diversity and social transformation professor of chemical engineering at the University of Michigan, to its board of directors, completing a term expiring in December 2022. The diversity and social transformation professorship was awarded to an inaugural group

By |2020-11-28T13:11:27-05:00November 28th, 2020|Life Sciences, Life Sciences/Biotech|

Priority Health Extends Zero Cost Share Programs, Sends COVID Safety Kits

GRAND RAPIDS—The health insurer Priority Health will continue to offer $0 cost share virtual care and telehealth services, including medical, behavioral health and substance use telemedicine, for nearly all fully funded HSA and non-HSA plans ahead of deductible, into 2021, company officials said. This will now be a standard benefit for most fully funded employer-sponsored

By |2020-11-12T19:41:41-05:00November 12th, 2020|Featured, Life Sciences, Life Sciences/Biotech|

Pfizer Reports Initial COVID-19 Vaccine In Clinical Tests 90 Percent Effective

NEW YORK - Pfizer and its German partner BioNTech SE gave the world an early Christmas present when they announced initial clinical studies show a COVID-19 vaccine was 90 percent effective. What’s more, in a press release, the companies said based on current projections the pharma companies expect to produce globally up to 50 million

By |2020-11-09T09:02:12-05:00November 9th, 2020|Featured, Life Sciences, Life Sciences/Biotech|